-+ 0.00%
-+ 0.00%
-+ 0.00%

TVARDI THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2 CLINICAL TRIAL OF TTI-101 IN IDIOPATHIC PULMONARY FIBROSIS

Reuters·05/27/2025 12:00:03

Please log in to view news